Novartis has entered into an agreement to sell 53.3 million (approximately 33%) Roche bearer shares in a bilateral transaction to Roche for a consideration of USD 20.7 billion. Novartis had acquired the stake between 2001 and 2003 for approximately USD 5
Tags :Baker McKenzie
Baker McKenzie assisted a privately held investment company in the sale of a real estate portfolio consisting of five commercial properties with development potential in Steinhausen, Rotkreuz and Cham (canton of Zug), and a commercial
Viseca, a provider of products and services in the area of cashless payment, from the issue of payment cards to the development of innovative finance management solutions, has secured a comprehensive refin
Varia US Properties, a Swiss-based real estate company investing exclusively in US multifamily housing with a focus on secondary and tertiary markets, has successful issued a CHF 50 million fixed-rate bond with a coupon of 2.875% and
Sensonor, a Norwegian company specialising in designing and manufacturing high-precision tactical grade gyro sensors, gyro modules and IMUs for demanding applications, has joined Safran Electronics & Defense for inertial navigation systems. With this acquisition, Safran
Cosmo Pharmaceuticals and Cassiopea have entered into a transaction agreement under which Cosmo is launching a public exchange offer in Switzerland to acquire all of the publicly-held registered shares of Cassiopea. The public exchange offer
Aryzta, a global food business based in Switzerland and listed on the SIX, has entered into an underwritten agreement with three banks for a new €500 million revolving credit facility. The facility which is expected to
Baker McKenzie advised International Schools Partnership (ISP) in the acquisition of two new schools — the British School of Geneva and Ecole Mosaic — in the Geneva region. ISP considers both schools a great addition to the
Anjarium Biosciences, a Swiss biotech company, recently closed a CHF 55.5 million (USD 61 million) Series A financing round, co-led by Gimv and Abingworth. The fundraising also saw significant participation from Omega Funds, Pfizer Ventures and surveyor
Patrimonium Private Equity, a Swiss private markets investment manager operating across the real estate, private debt, private equity and infrastructure asset classes, is investing in Octo Actuators, a fast-growing company in the sector of integrated
